SOURCE: The Bedford Report

The Bedford Report

April 20, 2010 12:00 ET

Complimentary Analyst Research on Sirius XM Radio, Inc. (NASDAQ: SIRI), Human Genome Sciences, Inc. (NASDAQ: HGSI), US Bancorp (NYSE: USB), Johnson & Johnson (NYSE: JNJ) and Many More Available at

Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report

TORONTO--(Marketwire - April 20, 2010) -  The Bedford Report is pleased to announce that its latest Market Update analyzing recent news and events on Sirius XM Radio, Inc. (NASDAQ: SIRI), Human Genome Sciences, Inc. (NASDAQ: HGSI), US Bancorp (NYSE: USB) and Johnson & Johnson (NYSE: JNJ) has been released.

In this issue of The Bedford report we predict whether or not Sirius' price will be able to stay above the $1 hurdle going forward. We also provide in-depth analysis of Johnson & Johnson and US Bancorp's earnings. And after Human Genome Sciences reported mediocre long-term data from a Phase III study for its lupus drug, Benlysta, we address the company's earning potential going forward. There is much more analysis regarding these companies and many more available at

Our updated analyst reports on Sirius, Human Genome Sciences, US Bancorp and Johnson & Johnson include:

  • An unbiased view and rating of the company
  • Recent key developments
  • Solid analyst summary -- who's saying what and why?
  • In-depth industry analysis and outlook
  • Major upcoming events to watch out for

Take the few minutes to register with us at and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action. has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.

Please view the full disclaimer:

Contact Information